2024 Q4 Form 10-Q Financial Statement
#000106299324020664 Filed on December 16, 2024
Income Statement
Concept | 2024 Q4 | 2023 Q4 |
---|---|---|
Revenue | $0.00 | |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $835.3K | |
YoY Change | 103.34% | |
% of Gross Profit | ||
Research & Development | $361.5K | |
YoY Change | 191.58% | |
% of Gross Profit | ||
Depreciation & Amortization | $5.560K | |
YoY Change | -1.59% | |
% of Gross Profit | ||
Operating Expenses | $1.227M | |
YoY Change | 117.64% | |
Operating Profit | ||
YoY Change | ||
Interest Expense | $96.20K | $63.54K |
YoY Change | 51.4% | -35.04% |
% of Operating Profit | ||
Other Income/Expense, Net | $7.550K | |
YoY Change | ||
Pretax Income | -$1.378M | |
YoY Change | 101.37% | |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$628.4K | -$1.378M |
YoY Change | -54.41% | 101.37% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | -$0.01 | -$0.03 |
Diluted Earnings Per Share | -$0.01 | -$0.03 |
COMMON SHARES | ||
Basic Shares Outstanding | 55.79M shares | 40.36M shares |
Diluted Shares Outstanding | 55.79M shares | 40.36M shares |
Balance Sheet
Concept | 2024 Q4 | 2023 Q4 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $686.3K | |
YoY Change | 311.41% | |
Cash & Equivalents | $279.7K | $686.3K |
Short-Term Investments | ||
Other Short-Term Assets | $114.7K | |
YoY Change | -68.7% | |
Inventory | ||
Prepaid Expenses | $152.1K | $114.7K |
Receivables | $7.180K | |
Other Receivables | $0.00 | |
Total Short-Term Assets | $954.5K | $808.2K |
YoY Change | 18.11% | 33.29% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $522.9K | |
YoY Change | -4.19% | |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $4.240M | $4.672M |
YoY Change | -9.26% | -0.49% |
TOTAL ASSETS | ||
Total Short-Term Assets | $954.5K | $808.2K |
Total Long-Term Assets | $4.240M | $4.672M |
Total Assets | $5.194M | $5.480M |
YoY Change | -5.22% | 3.38% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $918.0K | |
YoY Change | 88.07% | |
Accrued Expenses | ||
YoY Change | ||
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $2.527M | $1.001M |
YoY Change | 152.3% | 85.51% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $1.532M | |
YoY Change | 2.7% | |
Other Long-Term Liabilities | $222.5K | |
YoY Change | -37.49% | |
Total Long-Term Liabilities | $1.754M | |
YoY Change | -5.04% | |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $2.527M | $1.001M |
Total Long-Term Liabilities | $1.754M | |
Total Liabilities | $2.793M | $2.755M |
YoY Change | 1.38% | 15.43% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$30.86M | -$28.05M |
YoY Change | 10.04% | 18.38% |
Common Stock | $55.79K | $40.36K |
YoY Change | 38.21% | 23.1% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $2.401M | $2.725M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $5.194M | $5.480M |
YoY Change | -5.22% | 3.38% |
Cashflow Statement
Concept | 2024 Q4 | 2023 Q4 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$628.4K | -$1.378M |
YoY Change | -54.41% | 101.37% |
Depreciation, Depletion And Amortization | $5.560K | |
YoY Change | -1.59% | |
Cash From Operating Activities | -$455.0K | -$512.9K |
YoY Change | -11.28% | 68.09% |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | $21.00K | $0.00 |
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | $470.0K | $440.9K |
YoY Change | 6.61% | |
NET CHANGE | ||
Cash From Operating Activities | -$455.0K | -$512.9K |
Cash From Investing Activities | $21.00K | $0.00 |
Cash From Financing Activities | $470.0K | $440.9K |
Net Change In Cash | $36.02K | -$71.99K |
YoY Change | -150.03% | -76.41% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$455.0K | -$512.9K |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q4 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
34677 | usd |
CY2024Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
117468 | usd |
CY2023Q4 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
440868 | usd |
CY2024Q4 | us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
-40927 | usd |
CY2024Q4 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
162508 | usd |
CY2024Q3 | ryes |
Cumulative Translation Adjustment
CumulativeTranslationAdjustment
|
104084 | usd |
CY2024Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-30863010 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-30234617 | usd |
CY2024Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2400560 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2377670 | usd |
CY2024Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5194044 | usd |
CY2024Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5155398 | usd |
CY2024Q4 | us-gaap |
Accretion Expense
AccretionExpense
|
29859 | usd |
CY2023Q4 | us-gaap |
Accretion Expense
AccretionExpense
|
30113 | usd |
CY2024Q4 | us-gaap |
Legal Fees
LegalFees
|
55106 | usd |
CY2023Q4 | us-gaap |
Legal Fees
LegalFees
|
52583 | usd |
CY2024Q4 | us-gaap |
Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
|
30000 | usd |
CY2024Q4 | ryes |
Geological Mineral And Prospect Costs
GeologicalMineralAndProspectCosts
|
45162 | usd |
CY2023Q4 | ryes |
Geological Mineral And Prospect Costs
GeologicalMineralAndProspectCosts
|
361525 | usd |
CY2024Q4 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
96201 | usd |
CY2023Q4 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
63543 | usd |
CY2024Q4 | us-gaap |
Professional Fees
ProfessionalFees
|
100881 | usd |
CY2023Q4 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-75348 | usd |
CY2023Q4 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-512857 | usd |
CY2024Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
36016 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-71989 | usd |
CY2023Q4 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
90361 | usd |
CY2024Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
279685 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
243669 | usd |
CY2024Q4 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
11153 | usd |
CY2024Q3 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
21971 | usd |
CY2024Q4 | us-gaap |
Assets Current
AssetsCurrent
|
954513 | usd |
CY2024Q3 | us-gaap |
Assets Current
AssetsCurrent
|
894638 | usd |
CY2024Q4 | us-gaap |
Mineral Properties Net
MineralPropertiesNet
|
4128053 | usd |
CY2024Q3 | us-gaap |
Mineral Properties Net
MineralPropertiesNet
|
4149053 | usd |
CY2024Q3 | us-gaap |
Assets
Assets
|
5155398 | usd |
CY2024Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
874589 | usd |
CY2024Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2526605 | usd |
CY2024Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2661598 | usd |
CY2024Q4 | us-gaap |
Liabilities
Liabilities
|
2793484 | usd |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
400000000 | shares |
CY2024Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
55785106 | shares |
CY2024Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
55785 | usd |
CY2024Q4 | ryes |
Cumulative Translation Adjustment
CumulativeTranslationAdjustment
|
104084 | usd |
CY2023Q4 | us-gaap |
Accretion Expense
AccretionExpense
|
30113 | usd |
CY2024Q4 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
0 | usd |
CY2023Q4 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-82481 | usd |
CY2024Q4 | us-gaap |
Increase Decrease In Receivables
IncreaseDecreaseInReceivables
|
-10818 | usd |
CY2023Q4 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-25317 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
243669 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
758272 | usd |
CY2024Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
279685 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
686283 | usd |
CY2020Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
40000000 | shares |
CY2024Q4 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2024Q4 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
30-0692325 | |
CY2024Q4 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Vancouver | |
CY2024Q4 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
BC | |
CY2024Q4 | dei |
Entity Address Country
EntityAddressCountry
|
CA | |
CY2024Q4 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
V6C 0B4 | |
CY2024Q4 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2024Q4 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2024Q4 | us-gaap |
Assets
Assets
|
5194044 | usd |
CY2024Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
822414 | usd |
CY2024Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
55785 | usd |
CY2024Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
33311869 | usd |
CY2024Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
32660586 | usd |
CY2023Q4 | us-gaap |
Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
|
28022 | usd |
CY2024Q4 | ryes |
Filing And Regulatory Expense
FilingAndRegulatoryExpense
|
23997 | usd |
CY2023Q4 | ryes |
Filing And Regulatory Expense
FilingAndRegulatoryExpense
|
12907 | usd |
CY2024Q4 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-2127 | usd |
CY2023Q4 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-82481 | usd |
CY2024Q4 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-628393 | usd |
CY2023Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.03 | |
CY2024Q4 | us-gaap |
Interest Expense
InterestExpense
|
96201 | usd |
CY2023Q4 | us-gaap |
Interest Expense
InterestExpense
|
63543 | usd |
CY2024Q4 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-50373 | usd |
CY2023Q4 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
460562 | usd |
CY2023Q4 | us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
32281 | usd |
CY2024Q4 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-454984 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
3571861 | usd |
CY2020Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
400000000 | shares |
CY2024Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-628393 | usd |
CY2024Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-30863010 | usd |
CY2024Q4 | ryes |
Working Capital Deficiency
WorkingCapitalDeficiency
|
1572092 | usd |
CY2024Q3 | ryes |
Working Capital Deficiency
WorkingCapitalDeficiency
|
1766960 | usd |
CY2024Q4 | us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<div> <div> <div> <div> <div> <div> <div> <div> <div> <div> <div> <p style="margin-left:36pt;text-indent:-36pt;text-align:justify;margin-top:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>2.<span style="display:inline-block;width:28.5pt"> </span></strong><strong>BASIS OF PREPARATION</strong></span></span></p> <div> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Generally Accepted Accounting Principles</strong></span></span></p> <p style="margin-left:36pt;text-align:justify;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These unaudited condensed consolidated interim financial statements have been prepared in conformity with generally accepted accounting principles of the United States of America ("US GAAP") and the rules and regulations of the Securities and Exchange Commission ("SEC") for financial information with the instructions to Form 10-Q and Regulation S-K. Results are not necessarily indicative of results which may be achieved in the future. The unaudited condensed consolidated interim financial statements should be read in conjunction with the Company's Annual Report on Form 10-K, which contains the audited financial statements and notes thereto, together with Management's Discussion and Analysis, for the year ended July 31, 2024. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to such SEC rules and regulations. These financial statements follow the same accounting policies in the annual financial statements. The operating results for the three months ended October 31, 2024 are not necessarily indicative of the results that may be expected for the year ended July 31, 2025.</span></span></p> </div> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman,Times,serif;text-align:left"> </p> <div></div> <div> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Basis of Consolidation</strong></span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">These condensed consolidated interim financial statements include the accounts of the Company and its wholly-owned subsidiary, Rise Grass Valley Inc. All significant intercompany accounts and transactions have been eliminated on consolidation.</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><i>Subsidiaries</i></span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Subsidiaries are all entities over which the Company has exposure to variable returns from its involvement and has the ability to use power over the investee to affect its returns. The existence and effect of potential voting rights that are currently exercisable or convertible are considered when assessing whether the Company controls another entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company until the date on which control ceases.</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The accounts of subsidiaries are prepared for the same reporting period as the parent company, using consistent accounting policies. Intercompany transactions, balances and unrealized gains or losses on transactions are eliminated upon consolidation.</span></span></p> </div> <div> <p style="margin-left:35.45pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Use of Estimates</strong></span></span></p> <p style="margin-left:35pt;text-align:justify;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of these financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant areas requiring the use of estimates include the carrying value and recoverability of mineral properties and the recognition of deferred tax assets based on the change in unrecognized deductible temporary tax differences. Actual results could differ from those estimates and would impact future results of operations and cash flows.</span></span></p> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> | |
CY2024Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
40221 | usd |
CY2024Q3 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
56922 | usd |
CY2024Q4 | ryes |
Prepaid Deposits
PrepaidDeposits
|
106187 | usd |
CY2024Q3 | ryes |
Prepaid Deposits
PrepaidDeposits
|
48226 | usd |
CY2024Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
152145 | usd |
CY2024Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
117468 | usd |
CY2024Q3 | us-gaap |
Liabilities
Liabilities
|
2777728 | usd |
CY2024Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
400000000 | shares |
CY2024Q4 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
0 | usd |
CY2024Q3 | us-gaap |
Other Liabilities
OtherLiabilities
|
128949 | usd |
CY2024Q4 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2024Q4 | dei |
Document Type
DocumentType
|
10-Q | |
CY2024Q4 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2024Q4 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2024Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
152145 | usd |
CY2024Q4 | ryes |
Payable To Related Parties Current
PayableToRelatedPartiesCurrent
|
88022 | usd |
CY2024Q3 | ryes |
Payable To Related Parties Current
PayableToRelatedPartiesCurrent
|
128949 | usd |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-12987 | usd |
CY2024Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
74365 | usd |
CY2023Q4 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
145159 | usd |
CY2023Q4 | us-gaap |
Professional Fees
ProfessionalFees
|
337541 | usd |
CY2024Q4 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
8187 | usd |
CY2023Q4 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
20011 | usd |
CY2024Q4 | us-gaap |
Salaries And Wages
SalariesAndWages
|
0 | usd |
CY2023Q4 | us-gaap |
Salaries And Wages
SalariesAndWages
|
84301 | usd |
CY2024Q4 | ryes |
Other Income Operating
OtherIncomeOperating
|
0 | usd |
CY2023Q4 | ryes |
Other Income Operating
OtherIncomeOperating
|
7547 | usd |
CY2024Q4 | us-gaap |
Accretion Expense
AccretionExpense
|
29859 | usd |
CY2024Q4 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
470000 | usd |
CY2024Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5298511 | shares |
CY2024Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.34 | |
CY2023Q3 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
16661247 | shares |
CY2024 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
8768151 | shares |
CY2024 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
|
8717823 | shares |
CY2024 | ryes |
Warrants Expired Weighted Average Exercise Price
WarrantsExpiredWeightedAverageExercisePrice
|
0.92 | |
CY2024Q3 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
16711575 | shares |
CY2024Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.58 | |
CY2024Q4 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001424864 | |
CY2024Q4 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2024Q4 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-10-31 | |
CY2024Q4 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2024Q4 | dei |
City Area Code
CityAreaCode
|
604 | |
CY2024Q4 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2024Q4 | ryes |
Write Off On Receivable
WriteOffOnReceivable
|
0 | usd |
CY2023Q4 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-1378425 | usd |
CY2024Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
55785106 | shares |
CY2023Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
40362800 | shares |
CY2024Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-628393 | usd |
CY2023Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1378425 | usd |
CY2024Q4 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
0 | usd |
CY2023Q4 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
5562 | usd |
CY2023Q4 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
90361 | usd |
CY2023Q4 | ryes |
Shares Subscribed In Advance
SharesSubscribedInAdvance
|
440868 | usd |
CY2024Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
2400560 | usd |
CY2023Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.91 | |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
243669 | usd |
CY2024Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
88022 | usd |
CY2024Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5298511 | shares |
CY2024Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.34 | |
CY2024Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
17686102 | shares |
CY2024Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.39 | |
CY2023Q4 | us-gaap |
Interest Expense
InterestExpense
|
63543 | usd |
CY2024Q4 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | segment |
CY2024Q4 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--07-31 | |
CY2024Q4 | dei |
Entity File Number
EntityFileNumber
|
000-53848 | |
CY2024Q4 | dei |
Entity Registrant Name
EntityRegistrantName
|
RISE GOLD CORP. | |
CY2024Q4 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2024Q4 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2024Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
55785106 | shares |
CY2024Q4 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
1616169 | usd |
CY2024Q3 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
1658060 | usd |
CY2024Q4 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
175008 | usd |
CY2024Q3 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
0 | usd |
CY2024Q4 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
162508 | usd |
CY2023Q4 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
90361 | usd |
CY2024Q4 | us-gaap |
Profit Loss
ProfitLoss
|
-628393 | usd |
CY2023Q4 | us-gaap |
Profit Loss
ProfitLoss
|
-1239053 | usd |
CY2023Q4 | ryes |
Write Off On Receivable
WriteOffOnReceivable
|
-64438 | usd |
CY2024Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
CY2024Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | |
CY2023Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1378425 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
2724665 | usd |
CY2024Q4 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
162508 | usd |
CY2024Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
279685 | usd |
CY2024Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
140945 | usd |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
0 | usd |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3638500 | shares |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.93 | |
CY2024 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2110011 | shares |
CY2024 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.29 | |
CY2024 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
170000 | shares |
CY2024 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
1 | |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5578511 | shares |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.69 | |
CY2024Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2013500 | shares |
CY2024Q4 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.15 | |
CY2024Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
2293500 | shares |
CY2024Q4 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
1.01 | |
CY2024Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
4582514 | shares |
CY2024Q4 | ryes |
Warrants Issued Weighted Average Exercise Price
WarrantsIssuedWeightedAverageExercisePrice
|
0.21 | |
CY2024Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
17686102 | shares |
CY2024Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.39 | |
CY2024Q4 | dei |
Local Phone Number
LocalPhoneNumber
|
260-4577 | |
CY2024Q3 | ryes |
Assets Held For Sale
AssetsHeldForSale
|
511530 | usd |
CY2024Q4 | ryes |
Deferred Financing Asset
DeferredFinancingAsset
|
111478 | usd |
CY2024Q3 | ryes |
Deferred Financing Asset
DeferredFinancingAsset
|
111707 | usd |
CY2024Q4 | us-gaap |
Line Of Credit
LineOfCredit
|
91871 | usd |
CY2024Q3 | us-gaap |
Line Of Credit
LineOfCredit
|
116130 | usd |
CY2024Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
55785106 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
55785106 | shares |
CY2024Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
55785106 | shares |
CY2023Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.03 | |
CY2024Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
55785106 | shares |
CY2023Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
40362800 | shares |
CY2024Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-628393 | usd |
CY2024Q4 | ryes |
Warrants Issued For Financing Expense
WarrantsIssuedForFinancingExpense
|
488775 | usd |
CY2024Q1 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
1000000 | usd |
CY2024Q1 | us-gaap |
Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
|
0.12 | pure |
CY2024Q1 | ryes |
Class Of Warrant Or Right Number Of Warrants Granted During Period
ClassOfWarrantOrRightNumberOfWarrantsGrantedDuringPeriod
|
1000000 | shares |
CY2024Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
0.16 | |
CY2024Q1 | ryes |
Description Of Additional Warrants
DescriptionOfAdditionalWarrants
|
In addition, for each $100,000 loaned under the arrangement, the Company has agreed to issue to the lender 200,000 additional non-transferable warrants ("Additional Warrants"). | |
CY2024 | ryes |
Warrants Issued Weighted Average Exercise Price
WarrantsIssuedWeightedAverageExercisePrice
|
0.26 | |
CY2024Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
|
3607987 | shares |
CY2024Q4 | ryes |
Warrants Expired Weighted Average Exercise Price
WarrantsExpiredWeightedAverageExercisePrice
|
1.02 | |
CY2024Q4 | us-gaap |
Interest Expense
InterestExpense
|
96201 | usd |
CY2024Q4 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2025 | |
CY2024Q4 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
650-669 Howe Street | |
CY2024Q4 | ryes |
Assets Held For Sale
AssetsHeldForSale
|
511530 | usd |
CY2024Q4 | ryes |
Proceeds From Rental Of Land
ProceedsFromRentalOfLand
|
21000 | usd |
CY2023Q4 | ryes |
Proceeds From Rental Of Land
ProceedsFromRentalOfLand
|
0 | usd |
CY2024Q4 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
21000 | usd |
CY2023Q4 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
CY2024Q4 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
30000 | usd |
CY2023Q4 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
0 | usd |
CY2024Q4 | us-gaap |
Proceeds From Other Debt
ProceedsFromOtherDebt
|
500000 | usd |
CY2023Q4 | us-gaap |
Proceeds From Other Debt
ProceedsFromOtherDebt
|
0 | usd |
CY2024Q4 | ryes |
Shares Subscribed In Advance
SharesSubscribedInAdvance
|
0 | usd |
CY2023Q4 | ryes |
Shares Subscribed In Advance
SharesSubscribedInAdvance
|
440868 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
2377670 | usd |
CY2024Q4 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div> <div> <div> <p style="text-align:justify;margin-top:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>1.</strong><span style="display:inline-block;width:28.5pt"> </span><strong>NATURE AND CONTINUANCE OF OPERATIONS</strong></span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Rise Gold Corp. (the "Company") was originally incorporated as Atlantic Resources Inc. in the State of Nevada on February 9, 2007 and is in the exploration stage. On April 11, 2012, the Company merged its wholly-owned subsidiary, Patriot Minefinders Inc., a Nevada corporation, in and to the Company to effect a name change to Patriot Minefinders Inc. On January 14, 2015, the Company completed a name change to Rise Resources Inc. in the same manner. On March 29, 2017, the Company changed its name to Rise Gold Corp. These mergers were carried out solely for the purpose of effecting these changes of names.</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On September 18, 2020, the Company increased its authorized capital from 40,000,000 shares to 400,000,000 shares. </span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">On January 29, 2016, the Company completed an initial public offering in Canada and began trading on the Canadian Securities Exchange ("CSE") on February 1, 2016.</span></span></p> <p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company is in the early stages of exploration and as is common with any exploration company, it raises financing for its acquisition activities. The accompanying consolidated financial statements have been prepared on the going concern basis, which presumes that the Company will continue operations for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of business. The Company has incurred a loss of $628,393 for the period ended October 31, 2024 and has accumulated a deficit of $30,863,010. The ability of the Company to continue as a going concern is dependent on the Company's ability to maintain continued support from its shareholders and creditors and to raise additional capital and implement its business plan. There is no assurance that the Company will be able to obtain adequate financing in the future or that such financing will be on terms advantageous to the Company. These events and conditions cast substantial doubt about the Company's ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</span></span></p> <p style="margin-left:36pt;text-align:justify;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">At October 31, 2024, the Company had a working capital deficit of $1,572,092 (July 31, 2024 - $1,766,960).</span></span></p> </div> </div> </div> | |
CY2024Q4 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="margin-left:35.45pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>Use of Estimates</strong></span></span></p> <p style="margin-left:35pt;text-align:justify;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of these financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant areas requiring the use of estimates include the carrying value and recoverability of mineral properties and the recognition of deferred tax assets based on the change in unrecognized deductible temporary tax differences. Actual results could differ from those estimates and would impact future results of operations and cash flows.</span></span></p> </div> | |
CY2024Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
5737 | usd |
CY2024Q3 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
12320 | usd |
CY2024Q4 | us-gaap |
Derivative Loss On Derivative
DerivativeLossOnDerivative
|
0 | usd |
CY2023Q4 | us-gaap |
Derivative Loss On Derivative
DerivativeLossOnDerivative
|
82481 | usd |
CY2024Q4 | ryes |
Warrants Expired Unexercised
WarrantsExpiredUnexercised
|
2291322 | usd |
CY2024Q1 | ryes |
Fair Value Of Warrant
FairValueOfWarrant
|
127336 | usd |
CY2024Q4 | ryes |
Class Of Warrant Or Right Number Of Warrants Granted During Period
ClassOfWarrantOrRightNumberOfWarrantsGrantedDuringPeriod
|
1700000 | shares |
CY2024Q4 | ryes |
Class Of Warrant Or Right Granted During Period Exercise Price
ClassOfWarrantOrRightGrantedDuringPeriodExercisePrice
|
0.115 | |
CY2024Q4 | ryes |
Class Of Warrant Or Right Granted During Period Fair Value Of Warrants
ClassOfWarrantOrRightGrantedDuringPeriodFairValueOfWarrants
|
154351 | usd |
CY2024Q4 | ryes |
Class Of Warrant Or Right Number Of Finders Warrants Issued
ClassOfWarrantOrRightNumberOfFindersWarrantsIssued
|
2882514 | shares |
CY2024Q4 | ryes |
Class Of Warrant Or Right Granted During Period Exercise Price
ClassOfWarrantOrRightGrantedDuringPeriodExercisePrice
|
0.1735 | |
CY2024Q4 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
334423 | usd |